My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,071.64 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

99 100 Next >

2 Volatile Stocks with Impressive Fundamentals and 1 Facing Headwinds

November 10, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds

November 10, 2025

New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers...

Via MarketMinute

Here's How Much $100 Invested In Eli Lilly 15 Years Ago Would Be Worth Today ↗

November 10, 2025

Via Benzinga

MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? ↗

November 10, 2025

Via Stocktwits

Eli Lilly Stock Surges As Analyst Sees More Room To Run ↗

November 10, 2025

Eli Lilly shares are rising Monday after Leerink Partners upgraded the stock to Outperform and raised its price target to $1,104.

Via Benzinga

Tech Titans Lead the Charge: A Deep Dive into Sector Performance in the Current Market Rally

November 10, 2025

The stock market, as of November 10, 2025, continues its robust rally, defying earlier recessionary fears and exhibiting significant growth across several key sectors. At the heart of this resurgence...

Via MarketMinute

Topics Artificial Intelligence Economy

Why Eli Lilly (LLY) Stock Is Trading Up Today

November 10, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.9% in the afternoon session after Leerink Partners upgraded the stock to Outperform from Market Perform and significantly raised...

Via StockStory

Topics Artificial Intelligence

Stay informed with the top movers within the S&P500 index on Monday. ↗

November 10, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Markets Cheer As Shutdown End Nears: These 15 Stocks Are Rallying ↗

November 10, 2025

Markets rallied sharply Monday morning as Congress edged closer to a deal that could end the longest U.S. government shutdown in history.

Via Benzinga

Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration ↗

November 10, 2025

MeiraGTx shares rise after signing a $475 million deal with Eli Lilly for a gene therapy program restoring vision in children with LCA4.

Via Benzinga

This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

November 10, 2025

Via Benzinga

Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 10, 2025

Via Benzinga

12 Analysts Have This To Say About Eli Lilly ↗

November 10, 2025

Via Benzinga

This Eli Lilly Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

November 10, 2025

Via Benzinga

2 Monster Stocks in the Making ↗

November 10, 2025

There might still be time to get in on the ground floor.

Via The Motley Fool

2 Growth Stocks with All-Star Potential and 1 We Question

November 09, 2025

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 Drugs ↗

November 09, 2025

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Via The Motley Fool

The Algorithmic Imperative: Navigating AI’s Ethical Labyrinth in American Healthcare

November 09, 2025

As of November 2025, Artificial Intelligence (AI) has rapidly transitioned from a futuristic concept to an indispensable tool in American healthcare, profoundly reshaping diagnostics, treatment, and...

Via TokenRing AI

Topics Artificial Intelligence

Is There a Future for Viking Therapeutics? ↗

November 09, 2025

The weight loss drug company was counted out far too early in the summer, but investors are warming to it again.

Via The Motley Fool

Huge News for Eli Lilly Stock and Novo Nordisk Stock Investors as Companies Make Deal With Trump ↗

November 09, 2025

The companies announced a huge deal that will have implications for investors.

Via The Motley Fool

Topics World Trade

Organon (OGN) Reports Earnings Tomorrow: What To Expect

November 08, 2025

Pharmaceutical company Organon (NYSE:OGN) will be announcing earnings results this Monday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

Eli Lilly And These AI Plays Lead 5 Stocks Near Buy Points ↗

November 08, 2025

Eli Lilly stock and a pair of AI plays lead this watch list of stocks near buy points as the S&P 500 makes a stand at a key support level.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

This Unstoppable Growth Stock Just Gave Investors More Reasons to Buy ↗

November 08, 2025

The stock didn't stay down for too long.

Via The Motley Fool

Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030 ↗

November 08, 2025

It could become the first trillion-dollar pharmaceutical company in the process.

Via The Motley Fool

Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors. ↗

November 08, 2025

Weight loss drugs generated about $10 billion for Lilly in the most recent quarter.

Via The Motley Fool

Topics Government

Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance ↗

November 08, 2025

Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying building a chip fab like TSMC's is "extremely hard."

Via Benzinga

S&P 500: The Bull Market Is Just Getting Started

November 07, 2025

The S&P 500 has been on an impressive ascent, with market sentiment in November 2025 largely skewed towards cautious optimism. After a robust year of gains, driven significantly by the "mania around...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

Why Novo Nordisk Stock Is Sinking This Week ↗

November 07, 2025

The global drugmaker is facing some headwinds related to tough competition.

Via The Motley Fool

Topics Government World Trade

Why Nvidia (NVDA) Stock Is Falling Today

November 07, 2025

Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) fell 4.1% in the afternoon session after the stock retreated amid renewed concerns about stretched valuations in the AI space and...

Via StockStory

Topics Artificial Intelligence

Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment ↗

November 07, 2025

Eli Lilly's eloralintide cut body weight by up to 20% in a Phase 2 trial, showing strong efficacy and potential to advance obesity treatment.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.